Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05613283

Primary Cervical Cancer Screening by Self-sampling HPV Test

Sponsor: Peking University People's Hospital

View on ClinicalTrials.gov

Summary

Cervical cancer seriously threatens women's health and HPV infection is the main cause of cervical cancer. Traditionally, Cervical cancer screening is based on cervical exfoliated cell samples collected by health care provider, which is labor consuming and the coverage and compliance are both relatively low in some areas. Non-invasive hrHPV self-sampling test appears to be more acceptable and may improve the HPV screening coverage. This study aims to evaluate the clinical performance of a newly developed urine/vaginal self-sampling hrHPV test in Cervical cancer screening.

Key Details

Gender

FEMALE

Age Range

21 Years - 65 Years

Study Type

OBSERVATIONAL

Enrollment

17875

Start Date

2022-11-19

Completion Date

2027-08-31

Last Updated

2023-12-21

Healthy Volunteers

Yes

Locations (6)

Peking University People's Hospital

Beijing, Beijing Municipality, China

Henan Cancer Hospital

Zhengzhou, Henan, China

The Third Affiliated Hospital of Zhengzhou University

Zhengzhou, Henan, China

Hunan Provincial Maternal and Child Health Care Hospital

Changsha, Hunan, China

Chengdu Women's and Children's Central Hospital

Chengdu, Sichuan, China

Women's Hospital School Of Medicine Zhejiang University

Hangzhou, Zhejiang, China